The largest database of trusted experimental protocols

8 protocols using igg1 pe isotype control

1

CD40 Expression Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For detection of CD40 expression, cells were cultured in flasks until approximately 80% confluent. Alternatively, for treatment with cytokines, cells were seeded in 24-well plates at 5 × 104 cells/well and, after overnight incubation, they were treated with fresh medium containing 103 units/ml TNF-α or IFN-γ (R&D Systems/Bio-Techne) for 48 h. Cells were then harvested, washed and re-suspended in FACS buffer22 (link). CD40 expression was detected using PE-conjugated mouse anti-human CD40 antibody and an isotype control IgG1-PE (BD Biosciences, Berks, UK). In all, 10,000 events were acquired on a Guava EasyCyte flow cytometer and results analysed using EasyCyte software (Millipore, Watford, UK).
+ Open protocol
+ Expand
2

Immunophenotyping and Cell Cycle Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with CD138 PE-Cy5 (Beckman Coulter), CD38 PE, Isotype Control IgG1 PE, CXCR4 PE, or CD44 FITC (BD Pharmingen), CD74 FITC (Abcam), and Blimp1 Alexa-Fluor 488 (R&D) by standard procedures. All flow cytometry analysis used the BD FACScan, the BioRad S3 Cell Sorter and data was analyzed using CellQuest software. Cells were stained with Vybrant DyeCycle Green Stain (Invitrogen) and cell cycle analysis was performed using CellQuest software. Freshly sorted populations were also resuspended in methylcellulose (Stem Cell Technologies) at 104 cells/ml as per manufacturer’s instructions. Colonies were counted manually and photographs were taken using a light microscope under 4X magnification. Colonies were measured using the annote tab to compare pixel number to the scale created by the Kodak film software.
+ Open protocol
+ Expand
3

Characterization of FLT3 Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA constructs and vectors were used as described before [9] (link), [25] (link). FLT3-I867S and FLT3-D839G constructs were generated using QuikChange II XL Site-Directed Mutagenesis Kit (Agilent, Santa Clara, CA). Denotation: W78: ITD1, Npos: ITD2, W51: ITD3. Figure S1 displays the locations and insertions respectively substitutions of the analyzed mutations.
The following antibodies were used: FLT3 (S18) and goat anti-mouse secondary antibody from Santa Cruz Biotechnology (Santa Cruz, CA). AKT, MAPK, pSTAT5 (Tyr694), pAKT (Ser473) and pMAPK (Thr202/Tyr204) all from Cell Signaling Technology (Danvers, MA). STAT5 from R&D Systems (Minneapolis, MN). β-actin and goat anti-rabbit secondary antibody from Sigma-Aldrich (St. Louis, MO). CD-135-PE from Beckman Coulter (Brea, CA). IgG1 PE Isotype control from BD Pharmingen (BD Bioscience, Franklin Lakes, NJ).
+ Open protocol
+ Expand
4

Quantifying Neutrophil Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell membrane expression of CD11b, CD63, and CD66b was measured. The samples were incubated for 30 min on ice with one of the following mixes: (A) mouse anti-human phycoerythrin (PE)-conjugated CD63+mouse anti-human FITC-conjugated CD66b, (B) mouse anti-human PE-conjugated CD11b+mouse anti-human FITC-conjugated CD66b, or (C) IgG1-PE isotype control and IgG1-FITC isotype control (all from BD Biosciences, San Diego, CA, USA) at a final concentration of 10 μg·mL−1. The PMNs were gated according to their relative size (forward scatter) and granularity (sideward scatter). The expression of the cell surface markers was calculated as the mean fluorescence intensity (MFI) and corrected for non-specific binding of isotype control antibodies.
+ Open protocol
+ Expand
5

CD46 Expression on T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were stained with αCD3-FITC (UCHT1, BD Bioscience), αCD4-Brilliant Violet 421 (RPA-T4, BD Bioscience), αCD8-PC5 (B9.11, Beckmann Coulter), αCD46-PE (MEM-258, Sigma-Aldrich), IgG1-PE isotype control (BD Bioscience), and LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit (Life Technologies) in the volumes indicated by the manufacturers. CD46 expression was determined on respectively CD4+CD8 and CD4-CD8+ cell populations following gating on first live cells and then CD3+ cells. Isolated and in vitro activated CD8+ and CD4+ T cells were stained with αCD46-PE (MEM-258) and LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit and the expression of CD46 was determined on the live cells. The isotype control antibody was used to visualize the background PE fluorescence signal. Data were acquired on a NovoCyte flow cytometer (ACEA Bioscience Inc.) and processed in FlowJo (Tree Star). The detailed gating strategy for all flow cytometry experiments is presented as supplemental figurers (Fig. 1S–4S). Fluorescent data was displayed using bi-exponential visualization according to best practice [14 (link)].
+ Open protocol
+ Expand
6

Modulating Immune Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The anti-PD-L1 mAb (clone 405.9A11) was previously validated (26 ) by Dr. Gordon J. Freeman (Dana-Farber Cancer Institute, Boston, MA), anti-pJAK2(Y1007 and Y1008) (Abcam, Cambridge, UK) were used for IHC staining. The anti-PD-L1-PE (BD Pharmingen, San Jose, CA) anti-HLA-ABC-FITC mAb (clone w6/32, E-biosciences, San Diego, CA), IgG1-PE isotype control, pSTAT1 Tyr701-PE, STAT1-PE and STAT3-PE (BD Biosciences, San Jose, CA), phospho-AKT(Thre308)-PE and primary anti-p44/42 MAPK(Erk1/2) and phospho-p44/42 MAPK(Erk1/2) (Thr202/Tyr204) and secondary anti-rabbit-PE antibodies (Cell Signaling, Danvers, MA). WB antibodies included rabbit anti-human JAK2, pJAK2 (y1007/1008), total AKT, pAKT, pERK and mouse anti-human β-actin (Cell signaling, Danvers, MA). IFNγ (R&D systems Minneapolis, MN) was used at 10IU/mL. IFNα2a (PBL Interferon Source, Piscataway, NJ) was used at 1000 IU/mL. JAK2 inhibitor BMS-911543 was characterized previously (25 (link)), provided by Bristol-Myers Squibb and used at 10uM. JAK1/3 inhibitor (ZM39923) (Tocris bioscience, Bristol, United Kingdom) was characterized previously (27 (link), 28 (link)) and was used at 10uM. Wortmannin (Cell Signaling, Danvers, MA) was used at a 1uM. PI3Kα110 subunit inhibitor (BYL-719) was used at a 1uM and MEK1/2 inhibitor (PD0325901) was used at 5uM (Tocris Bioscience, Bristol, UK).
+ Open protocol
+ Expand
7

Flow Cytometric Profiling of Skeletal Muscle Stem/Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was conducted using the skeletal muscle supernatant. Specific antibodies were used for cell labelling: CD34 antibody for stem/progenitor cells, CD44 and CD105 antibodies for MSCs, and CD45 antibody for haematopoietic lineage cells (all from BD Biosciences, Franklin Lakes, New Jersey). Samples underwent regular flow cytometric profiling with a FACSCalibur Analyser and CellQuest Pro Software (BD Biosciences Immunocytometry Systems, San Jose, California). Dead cells were excluded from the plots on the basis of propidium iodide (PI) staining (Sigma-Aldrich Corp., St Louis, Missouri). Cells were washed twice with Hanks’ balanced salt solution (HBSS) containing 3.0% heat-inactivated foetal bovine serum (FBS) and incubated with monoclonal antibodies for 30 minutes at 4°C after Fc recepter blocking reagent (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). The stained cells were washed three times with HBSS/3.0% FBS, resuspended in 0.5 mL of HBSS/3.0% FBS/PI, and analysed. The following monoclonal antibodies were used to identify the CD34+/CD45dim subpopulation (the stem/progenitor cell fraction), and the CD44+/CD105+ subpopulation (the MSC fraction): CD34-FITC (clone RAM34), CD44-APC (clone G44–26), CD105-PE (clone 266), CD45-FITC (clone HI30), IgG1-PE isotype control, and IgG1-FITC (all from BD Biosciences Pharmingen San Diego, California).
+ Open protocol
+ Expand
8

Quantifying HER-2/neu Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested after 24 h under normoxia or hypoxia and stained with an anti-HER-2/neu-PE (BD) antibody or with the IgG1-PE isotype control (BD), respectively, for 20 min as recently described [47 (link)]. Fluorescence intensity was determined by flow cytometry (FACSCalibur, BD). The results were expressed as mean specific fluorescence intensity (MFI). Three independent experiments were performed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!